Posted by Michael Wonder on 16 May 2022
Pfizer and BioNTech provide update on COVID-19 vaccine supply agreement with European Commission
13 May 2022 - May 13, 2022 — Pfizer and BioNTech today announced they have reached an agreement with the European Commission to amend their originally agreed contractual delivery schedules for the Pfizer-BioNTech COVID-19 Vaccine.
This amendment rephases planned deliveries to help support the European Commission and Member States' on-going immunization programs, and is aligned to the companies’ commitment to working collaboratively to identify pragmatic solutions to address the evolving pandemic needs.
